Anika Therapeutics Inc (ANIK)

40.76 -1.99  -4.65% NASDAQ Feb 24, 10:41 Delayed 2m USD

Anika Therapeutics Price to Book Value:

2.065 for Feb. 24, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Price to Book Value Chart

Export Data
Save Image
Print Image

Historical Price to Book Value Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Feb. 24, 2020 2.065
Feb. 21, 2020 2.166
Feb. 20, 2020 2.128
Feb. 19, 2020 2.156
Feb. 18, 2020 2.148
Feb. 14, 2020 2.101
Feb. 13, 2020 2.103
Feb. 12, 2020 2.128
Feb. 11, 2020 2.120
Feb. 10, 2020 2.121
Feb. 7, 2020 2.095
Feb. 6, 2020 2.145
Feb. 5, 2020 2.149
Feb. 4, 2020 2.056
Feb. 3, 2020 2.039
Jan. 31, 2020 2.082
Jan. 30, 2020 2.175
Jan. 29, 2020 2.286
Jan. 28, 2020 2.290
Jan. 27, 2020 2.252
Jan. 24, 2020 2.223
Jan. 23, 2020 2.329
Jan. 22, 2020 2.316
Jan. 21, 2020 2.325
Jan. 17, 2020 2.301
Jan. 16, 2020 2.386
   
Jan. 15, 2020 2.420
Jan. 14, 2020 2.504
Jan. 13, 2020 2.519
Jan. 10, 2020 2.523
Jan. 9, 2020 2.540
Jan. 8, 2020 2.629
Jan. 7, 2020 2.681
Jan. 6, 2020 2.739
Jan. 3, 2020 2.618
Jan. 2, 2020 2.654
Dec. 31, 2019 2.627
Dec. 30, 2019 2.648
Dec. 27, 2019 2.676
Dec. 26, 2019 2.684
Dec. 24, 2019 2.685
Dec. 23, 2019 2.649
Dec. 20, 2019 2.656
Dec. 19, 2019 2.691
Dec. 18, 2019 2.703
Dec. 17, 2019 2.753
Dec. 16, 2019 2.726
Dec. 13, 2019 2.692
Dec. 12, 2019 2.710
Dec. 11, 2019 2.748
Dec. 10, 2019 2.808

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

Price to Book Value Benchmarks

Benchmarks
Innoviva Inc 4.753
Vertex Pharmaceuticals Inc 10.16
bluebird bio Inc 3.315

Price to Book Value Range, Past 5 Years

Minimum 1.583 Mar 13 2019
Maximum 3.923 Jul 01 2016
Average 2.798
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.